Skip to main content
logo
Nuvation Bio Inc. (NUVB)
NYSE: NUVB · Real-Time Price · USD
4.890
-0.150 (-2.98%)
At close: Apr 24, 2026, 4:00 PM EDT
4.930
+0.040 (0.82%)
After-hours: Apr 24, 2026, 7:44 PM EDT

Nuvation Bio Revenue

In the year 2025, Nuvation Bio had annual revenue of $62.90M with 698.96% growth. Nuvation Bio had revenue of $41.87M in the quarter ending December 31, 2025, with 633.06% growth.

Revenue (ttm)
$62.90M
Revenue Growth
+698.96%
P/S Ratio
27.03
Revenue / Employee
$211,081
Employees
298
Market Cap
1.70B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202562.90M55.03M698.96%
Dec 31, 20247.87M--
Dec 31, 2023---
Dec 31, 2022---
Dec 31, 2021---
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Innoviva411.33M
Vericel276.26M
Nurix Therapeutics71.78M
Vir Biotechnology68.56M
Taysha Gene Therapies9.77M
AtaiBeckley4.09M
Inhibrx Biosciences1.30M
Revenue Rankings

NUVB News

More News